Skip to main content
. 2022 Sep 1;13(10):1634–1641. doi: 10.1021/acsmedchemlett.2c00310

Figure 4.

Figure 4

αMe introduction at the 3rd and 4th positions of compound 4. aInhibitory activity of HIV-1 protease measured by the fluorogenic peptide cleavage assay. bAnti-HIV-1 activity assay using the human T cell line (MT-4 cells). cMetabolic stability using human liver S9.